PRDX2 and hepatocellular carcinoma: The discrepancy between these studies may be explained by heterogeneity in PRDX2 expression among patients, a differential PRDX2 expression during disease stage, and several factors such as disease etiology, HCC grade, immune cell infiltration, and cooccurrence of mutations in patients (22).